Treatment of presensitization with IL-2 receptor antibody plus alloantigen.
Tyler
J D
JD
Department of Surgery, University of Tennessee Medical Center, Knoxville 37920.
Wierwille
S L
SL
Goldman
M H
MH
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000917:Antibody Formation; D006084:Graft Rejection; D007114:Immunization; D007165:Immunosuppression Therapy; D007376:Interleukin-2 / Q000276:immunology*; D007519:Isoantigens / Q000008:administration & dosage*; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D016038:Skin Transplantation; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D007519:Isoantigens; D015375:Receptors, Interleukin-2